Dr Alan Cameron
- Honorary Clinical Lecturer (Institute of Cardiovascular & Medical Sciences)
email:
Alan.Cameron.2@glasgow.ac.uk
Graduate School Office, Room 362, Wolfson Link Building, G12 8qq
Biography
Degrees
MB ChB, BSc (Hons), MRCP
Current Position
I am an Honorary Clinical Lecturer and Specialty Registrar in Clinical Pharmacology and Medicine at the University of Glasgow and NHS Greater Glasgow and Clyde.
Background
I graduated in Medicine from the University of Glasgow in 2010 and achieved an Intercalated BSc in Cardiovascular Medicine with First Class Honours in 2008. I completed early clinical academic training as part of the Glasgow Academic Training Environment (GATE) from 2010 to 2014, and a Clinical Teaching Fellowship in Medicine with Postgraduate Certificate in Health Professions Education (Merit) at the Western Infirmary Glasgow from 2014-15. I commenced a BHF Centre of Research Excellence PhD Fellowship at the University of Glasgow Institute of Cardiovascular and Medical Sciences in 2015 and I am currently an Honorary Clinical Lecturer and Specialty Registrar in Clinical Pharmacology and Medicine.
Research interests
Cardiovascular Complications of Chemotherapy
I play a fundamental role in a programme of novel and innovative translational cardio-oncology studies, focussing on the cardiovascular effects of cisplatin and VEGF inhibitor chemotherapy. Our research aims to successfully unravel the mechanisms whereby chemotherapy drugs cause vascular damage and identify approaches to maintain vascular health and prevent cardiovascular disease in patients treated with chemotherapy drugs that induce cardiovascular toxicity.
Stroke Medicine
I play an active role in research studies that aim to reduce the burden of stroke by improving approaches to primary and secondary prevention, as well as optimising the management of patients with acute stroke, including intravenous thrombolysis.
Presentations
Oral Presentations
Cameron AC, Delles C, Lang NN, Touyz RM. Masked Hypertension Contributing to Severe Hypertensive Heart Disease with Left Ventricular Outflow Tract Obstruction. American Heart Association’s Hypertension Scientific Sessions 2018.
Cameron AC, Abdul-Rahim AH, Bogie J, et al. Alteplase Dose for Acute Ischaemic Stroke:
Higher Absolute Doses are Associated with Favourable Functional Outcomes and Survival. 4th European Stroke Organisation Conference 2018.
Cameron AC, Bogie J, Abdul-Rahim AH, et al. Professional guideline versus product licence selection for treatment with IV thrombolysis: compliance with product licences is highest in lower efficiency sites and restricts thrombolysis usage. 3rd European Stroke Organisation Conference 2017.
Cameron AC, Hall M, Rios F, et al. Vascular effects of cisplatin-based chemotherapy for testicular cancer (VECTOR) study. Global Cardio-Oncology Summit 2017.
Cameron AC, Lees KR, Booth MG, et al. A survey of principal researchers who lead research into Adults with Incapacity in Scotland. 10th Congress of the European Association for Clinical Pharmacology and Therapeutics 2011.
Poster Presentations
Cameron AC, Welsh P, Touyz RM, Lang NN. Vascular effects of VEGF inhibition with bevacizumab in-vivo in man. British Pharmacological Society Annual Meeting 2018.
Cameron AC, Hall M, Rios F, Waterston A, White J, Youyz RM, Lang NN. Vascular effects of anti-cancer cisplatin therapy. 28th European Meeting on Hypertension and Cardiovascular Protection / European Society of Hypertension 2018.
Cameron AC, Chaudry F, Elliot E, Dawson J. Improving Cardiovascular Risk Factor Screening in Acute Stroke. Royal College of Physicians of Edinburgh Stroke Symposium 2018.
Cameron AC, Neves KB, Rios FJ, et al. Vascular endothelial growth factor inhibitors (VEGFI) induce endothelial cell activation in cancer patients. Global Cardio-Oncology Summit 2017.
Cameron AC, Neves KB, Rios FJ, Montezano AC, White J, Lang NN, Touyz RM. Molecular mechanisms underlying the vascular effects of cisplatin. Global Cardio-Oncology Summit 2017
Cameron AC, McCallum L, Gardiner T, et al. An audit of appropriate use of antithrombotic therapy in patients presenting with suspected acute coronary syndrome. 3rd International Triennial Conference of the Royal College of Physicians and Surgeons of Glasgow, 2014.
Cameron AC, Jenkins SMM, Sonecki P. Stress echocardiography in a University teaching hospital – a retrospective analysis. 7th International Conference of the Society for Acute Medicine, 2013.
Cameron AC, Dawson J, Quinn TJ, Lim WH, Walters MR. Dipyridamole therapy after stroke: adverse effects are common. 10th Congress of the European Association for Clinical Pharmacology and Therapeutics. Basic Clin Pharmacol Toxicol. 2011;109(s1):77.
Gallanagh S, Cameron AC, Walters MR. Thrombolysis for acute ischaemic stroke: a prospective analysis of resource challenges associated with providing a regional service. 10th Congress of the European Association for Clinical Pharmacology and Therapeutics. Basic Clin Pharmacol Toxicol. 2011;109(s1):99.
Dawson J, Cameron AC, Walters MW, et al. Neurological morbidity and mortality following attendance at a transient ischaemic attack clinic. International Stroke Conference, 2011. Stroke. 2011;42:e250.
Lim WY, Cameron AC, Dawson J, et al. Variation in the delivery of stroke unit care in Scottish hospitals: an interview-based survey and analysis. Scottish Society of Physicians Annual Meeting 2010. Scott Med J. 2011;56:49.
Cameron AC, Dawson J, Quinn TJ, et al. Permanent pacemaker insertion following attendance at a transient ischaemic attack clinic. 6th World Stroke Congress. Int. J. Stroke. 2008;3(s1):84.
Cameron AC, Dawson J, Quinn TJ, et al. Long-term outcome following attendance at a transient ischaemic attack clinic. 6th World Stroke Congress. Int. J. Stroke. 2008;3(s1):404.
Quinn TJ, Cameron AC, Dawson J, et al. ABCD2 score as a predictor of non-cerebrovascular diagnoses. 17th European Stroke Congress. Cerebrovasc. Dis. 2008;25(s2):169,2015
Grants
Grants and Awards listed are those received whilst working with the University of Glasgow.
- Preventing Recurrent Cardioembolic Stroke ¿ Right Approach, Right Patient
Mason Medical Research Foundation
2021 - 2023
- Preventing Recurrent Cardioembolic Stroke ¿ Right Approach, Right Patient
Royal College of Physicians and Surgeons of Glasgow
2021 - 2023
- Preventing Recurrent Cardioembolic Stroke¿
NHS Greater Glasgow and Clyde Endowment Funds
2021 - 2023
- Cancer Chemotherapeutics and the Vasculature - Endothelial Effects of VEGF Inhibitorsion In Vivo in Man
Chief Scientist Office
2016 - 2018
- Intermediate and Long Term Vascular Effects of Cisplatin in Patients with Testicular Cancer (INTELLECT)
Mason Medical Research Foundation
2016 - 2018